Internationally Renowned Researchers Join Resverlogix Corporation

CALGARY, ALBERTA -- (MARKET WIRE) -- December 20, 2006 -- Resverlogix Corp. (TSX: RVX) ("Resverlogix"), is pleased to announce today that it has named Drs. Philip Barter, M.D., Ph.D. and Prediman K. (P.K.) Shah, M.D. both highly respected cardiovascular researchers, to Resverlogix's newly formed Clinical Review Committee.

Back to news